Bioventus acquires BioStructures: 7 key notes

Written by Anuja Vaidya | December 01, 2015 | Print  |

Bioventus has completed its acquisition of BioStructures.

Here are seven key notes:

 

1. Bioventus is an orthobiologics company and BioStructures is a medical device company focused on developing bioresorbable bone graft products for spinal and orthopedic fusion procedures.

 

2. The agreement includes the acquisition of BioStructures' entire portfolio of products as well as its research and development pipeline.

 

3. The BioStructures product portfolio includes synthetic, allograft, collagen and demineralized bone matrix solutions.

 

4. The company's signature products include the Interface Bioactive Bonegraft and Signafuse Bioactive Bonegraft Putty.

 

5. In addition, employees of BioStructures will be given offers to join Bioventus.

 

6. Bioventus will continue to work with the current network of distributors carrying the BioStructures product portfolio.

 

7. Terms of the acquisition were not disclosed.

 

More articles on devices:
Less RA patients using assistive mechanical devices — 5 things to know
St. Jude Medical launches Proclaim Elite SCS System in Europe: 3 things to know
SI-BONE closes $39.2M credit facility: 5 key notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months